Halopropane

Halopropane
Clinical data
Trade names	Tebron
ATC code	None;
Identifiers
	IUPAC name 3-Bromo-1,1,2,2-tetrafluoropropane;
CAS Number	679-84-5;
PubChem CID	69623;
ChemSpider	62826;
UNII	3DC4A5894W;
CompTox Dashboard (EPA)	DTXSID40862366 ;
Chemical and physical data
Formula	C3H3BrF4
Molar mass	194.955 g·mol−1
3D model (JSmol)	Interactive image;
	SMILES C(C(C(F)F)(F)F)Br;
	InChI InChI=1S/C3H3BrF4/c4-1-3(7,8)2(5)6/h2H,1H2; Key:YVWGMAFXEJHFRO-UHFFFAOYSA-N;

Halopropane (synonym FHD-3, trade name Tebron) is a halocarbon drug which was investigated as an inhalational anesthetic but was never marketed.^[1] Its clinical development was terminated due to a high incidence of cardiac arrhythmias in patients, similarly to the cases of teflurane and norflurane.^[2]^[3]^[4]

References

^ Webster NR, Galley HF (22 August 2013). Landmark Papers in Anaesthesia. OUP Oxford. pp. 70–. ISBN 978-0-19-163319-5.
^ Acta anaesthesiologica Belgica. Acta Medica Belgica. 1974.
^ Klein SL (1993). A glossary of anesthesia and related terminology. Springer-Verlag. ISBN 978-0-387-97831-4.
^ Catcott EJ, Smithcors JF (1973). Progress in canine practice. American Veterinary Publications.

This drug article relating to the nervous system is a stub. You can help Wikipedia by expanding it.